Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "DNA"

244 News Found

Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
Drug Approval | August 12, 2021

Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%

It’s an AB-rated generic therapeutic version of Durezol


WACKER acquires plasmid DNA Manufacturer Genopis
News | February 05, 2021

WACKER acquires plasmid DNA Manufacturer Genopis

WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).


ZoBio launches DEL platform to accelerate drug discovery for challenging targets
Biopharma | June 15, 2026

ZoBio launches DEL platform to accelerate drug discovery for challenging targets

New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography


Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
interviews | June 08, 2026

Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences

We are building the bridge between complex molecular data and everyday clinical decisions


Abbott highlights prognostic value of MRD testing for breast cancer recurrence
Clinical Trials | June 03, 2026

Abbott highlights prognostic value of MRD testing for breast cancer recurrence

New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients


M|O|C Cancer Care’s research gains global recognition at ASCO 2026
Healthcare | June 02, 2026

M|O|C Cancer Care’s research gains global recognition at ASCO 2026

The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care


Pantherna acquisition to boost T-CURX’s clinical translation of non-viral In Vivo CAR-T strategies
Healthcare | June 01, 2026

Pantherna acquisition to boost T-CURX’s clinical translation of non-viral In Vivo CAR-T strategies

Proprietary technologies in LNP-based delivery of mRNA and DNA vectors to advance T-CURX innovative in vivo CAR-T assets into clinical trials one year earlier


FDA delays AstraZeneca decision on camizestrant as regulators seek more data
Drug Approval | May 30, 2026

FDA delays AstraZeneca decision on camizestrant as regulators seek more data

The filing is backed by results from the pivotal SERENA-6 Phase III trial


AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%
Clinical Trials | May 25, 2026

AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%

The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial